Displaying items 37-48 of 144
» View wsbt.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-12
•
Next >
-
CANADA STOCKS-TSX may open higher after Italy forms new gov't
ReutersApril 29 (Reuters) - Canada's main stock index looked set to open higher, with investors encouraged by the formation of a coalition government in Italy that ended two months of political uncertainty in the troubled region. TOP STORIES * New Italian...Tags: Government, Drugs and Medicines, Petroleum Industry, Kinross Gold Corporation, Metal and Mineral
-
Impax, GSK end Parkinson's disease partnership
ReutersApril 29 (Reuters) - Impax Laboratories Inc said partner GlaxoSmithKline Plc ended their collaboration on Impax's experimental Parkinson's disease drug due to regulatory and launch delays in the countries in which GSK has rights to market the drug. Impax...Tags: Parkinson's Disease, Diseases and Illnesses, Symptoms
-
FDA raises safety concerns on Valeant's seizure drug
ReutersApril 26 (Reuters) - The U.S. Food and Drug Administration said the an anti-seizure drug developed by Valeant Pharmaceuticals Inc and co-marketed with GlaxoSmithKline Plc may cause eye and skin problems. The U.S. health regulator warned that the drug,...Tags: Seizures, Food and Drug Administration, European Union, Thomson Corporation
-
Big pharma: Few new antibiotics in the works
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...
Tags: Tuberculosis, HIV, Research, MRSA, Bristol Myers Squibb Company
-
Fight tobacco marketing, boost vaccinations to curb cancer, says report
ReutersLONDON (Reuters) - Fighting the tobacco industry's tactics in the world's poorest countries and ensuring the best vaccines get to those most in need are key to cutting the number of cancer deaths worldwide, according to a report by specialists in the...Tags: Medical Research, Preventative Medicine, Drugs and Medicines, Human papillomavirus, Tobacco Products
-
Do soaps with triclosan do more harm than good?
If co-workers and family members are coming down with infections this winter, you may be tempted to turn to an anti-bacterial soap for protection. But some scientists are increasingly concerned that a common anti-bacterial ingredient called triclosan...
Tags: Natural Resources Defense Council, Science and Technology, Chemical Industry, U.S. Environmental Protection Agency, Aquaculture
-
State AG sues maker of diabetes drugs for false advertising
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
Tags: Diabetes, Heart Attack, Justice System, Crime, Law and Justice, Litigation
-
Amgen pleads guilty, to settle misbranding case for $762 million
Biotech giant Amgen Inc. pleaded guilty to a federal misdemeanor of misbranding its anemia drug Aranesp and has agreed to pay $762 million in fines and penalties. The Thousand Oaks company said it had reached a preliminary settlement of federal criminal...Tags: Amgen Inc., Anemia, Justice System, Medicare, Crime, Law and Justice
-
Corporations and execs need penalties that hurt
If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys. The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of...
Tags: Gulf of Mexico Oil Spill (2010), Mexico, Abbott Laboratories, Mortgages, Finance
-
Appeals court puts 1st Amendment over public health
The Food, Drug and Cosmetic Act makes it illegal to sell a prescription drug for any purpose other than what's listed on the label. Nevertheless, a divided federal appeals court this week tossed out the conviction of a former drug sales rep who was...Tags: Prescription Drugs, Capron, Viagra (drug), Fibromyalgia, Drugs and Medicines
-
Human Genome to lay off 97 workers
Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...Tags: Career and Workplace, Layoffs and Downsizing, Unemployment, Labor Legislation, Job Layoffs
-
EU advises all girls need cervical cancer vaccines
ReutersLONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday. In new advice about...Tags: Europe, Preventative Medicine, Cancer, Drugs and Medicines, Human papillomavirus
Apr 29, 2013
|Story| Reuters
Apr 29, 2013
|Story| Reuters
Apr 26, 2013
|Story| Reuters
Mar 19, 2013
|Story| Reuters
Mar 6, 2013
|Story| Reuters
Feb 10, 2013
|Story| Chicago Tribune
Feb 20, 2013
|Story| Baltimore Sun
Dec 18, 2012
|Story| Los Angeles Times
Jan 5, 2013
|Column| Los Angeles Times
Dec 7, 2012
|Column| Los Angeles Times
Oct 17, 2012
|Story| Baltimore Sun
Sep 4, 2012
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.